Clinical Trial of Radiation Therapy Offers Complete Treatment in Fewer Visits

Diagnosed with invasive ductal carcinoma, one of the most common types and earliest stages of breast cancer, Michele, a grandmother and full-time caregiver to her husband, is today cancer-free thanks to the radiation therapy she received at the Siteman Cancer Center.

The clinical trial was based on the use of the breakthrough ViewRay MRIdian technology, a UF startup, initially used by Washington University physicians at Siteman. Guided by continuous MRI, the radiation therapy system allows physicians to monitor tumors in real-time during the treatment. This allows the treatment team to see where the radiation dose is being delivered and to determine if any subtle changes are occurring to the tumor or surrounding tissue. The ability for continuous soft-tissue imaging means a patient’s treatment plan or radiation dose can be adjusted immediately if changes are noted.

Learn more about Clinical Trial of Radiation Therapy Offers Complete Treatment in Fewer Visits.